ReviewFrontiers in public health2022
Cervical cancer in Nepal: Current screening strategies and challenges.
Review in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and pathways to acceleration.Human vaccines & immunotherapeutics · 2026Article
- Cytopathology Trends in Nepal-Historic and Current Practices and Future Directions.Diagnostic cytopathology · 2026Review
- Cervical cancer prevention behaviors and determinants among Indigenous women in rural Nepal.Health promotion international · 2026Article
- Factors associated with cervical cancer screening uptake among women aged 30-49 years of Bhanu Municipality, Tanahun, Nepal: a cross-sectional study.BMC women's health · 2026Article
- Article
- Intersectionality of cancer disparities in south Asia.The Lancet. Global health · 2026Review
- Human papillomavirus (HPV) vaccine uptake and its associated factors among adolescent girls in Kathmandu District, Nepal: A cross-sectional study.PLOS global public health · 2026Article
- Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women, 1990-2021: Evidence from the GBD Study.International journal of women's health · 2026Article
- Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.BMC cancer · 2025Article
- Unlocking early detection: How screening can save lives from cervical cancer.World journal of clinical oncology · 2025Article
- Human papillomavirus vaccine: a welcome addition to the national immunisation schedule in Nepal.BMJ global health · 2025Article
- Associated risk factors and prevalence of human papillomavirus infection among females visiting tertiary care hospital: a cross-sectional study from Nepal.Open medicine (Warsaw, Poland) · 2025Article
- Are we ready for self-sampling for cervical cancer screening? Insights from service providers and policy makers in Nepal.PLOS global public health · 2025Article
- Triptolide induces immunogenic cell death in cervical cancer cells via ER stress and redox modulation.American journal of cancer research · 2025Article
- Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.Therapeutic advances in vaccines and immunotherapy · 2025Review
- Immunogenic cell death-related cancer-associated fibroblast clusters and prognostic risk model in cervical cancer.APL bioengineering · 2024Article
- Analysis of the global burden of cervical cancer in young women aged 15-44 years old.European journal of public health · 2024Article
- Article
- Asiatic acid inhibits cervical cancer cell proliferation and migration via PI3K/AKT/mTOR signaling pathway.Heliyon · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nepal has a high burden of cervical cancer primarily due to a limited screening program. Most present with advanced cervical disease. Despite no national cervical cancer control program, Nepal's Ministry of Health and Population has taken many initiatives with various international collaborations in screening, vaccination, and treating pre-invasive and invasive cancer. However, the existing prevention and treatment modalities are dismally inadequate to meet the targets of WHO's cervical cancer eliminative initiative by 2030. We provide an overview of the Ministry of Health and Population, Nepal's efforts to tackle the growing cervical cancer burden in the country. We discuss the challenges and potential solutions that could be practical and augment screening uptakes, such as single-dose vaccination and HPV DNA tests. The screen-and-treat approach on the same day could potentially address treatment delays and follow-up loss after testing positive. Our narrative summary highlights existing and innovative strategies, unmet needs, and collaborations required to achieve elimination across implementation contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.